These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13301918)

  • 41. Observations on the effect of largactil in psychiatric illness.
    BAKER AA
    J Ment Sci; 1955 Jan; 101(422):175-82. PubMed ID: 14368221
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical evaluation of azacyclonol, chlorpromazine, and reserpine on a group of chronic psychotic patients.
    RINALDI F; RUDY LH; HIMWICH HE
    Am J Psychiatry; 1956 Mar; 112(9):678-83. PubMed ID: 13292558
    [No Abstract]   [Full Text] [Related]  

  • 43. [General comments on largactil therapy in the Basel psychiatric university clinic].
    STAEHELIN JE
    Schweiz Arch Neurol Psychiatr; 1954; 73(1-2):288-91. PubMed ID: 13195582
    [No Abstract]   [Full Text] [Related]  

  • 44. The major complications of treatment of psychotic states with chlorpromazine and reserpine and their management.
    GOLDMAN D
    Psychiatr Res Rep Am Psychiatr Assoc; 1956 Apr; (4):79-88. PubMed ID: 13323115
    [No Abstract]   [Full Text] [Related]  

  • 45. Combined reserpine-chlorpromazine therapy in highly disturbed psychotics.
    TUTEUR W
    Am J Psychiatry; 1955 Sep; 112(3):206. PubMed ID: 13258878
    [No Abstract]   [Full Text] [Related]  

  • 46. [Reflections on treatment by largactil and serpasil].
    RANCE AM; JURQUET A; ROGER J
    Ann Med Psychol (Paris); 1956 Jul; 114(2):320-7. PubMed ID: 13340398
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of therapeutic value of largactil according to observations at the clinic for mental diseases of the Academy of Medicine in Gdańsk].
    FALICKI Z; GALUSZKO P; JAWORSKA I; KIELAK L; SULESTROWSKI W
    Neurol Neurochir Psychiatr Pol; 1956; 6(3):313-20. PubMed ID: 13348809
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of meprobamate in the treatment of psychotic patients.
    BARSA JA; KLINE NS
    Am J Psychiatry; 1956 Jun; 112(12):1023. PubMed ID: 13313819
    [No Abstract]   [Full Text] [Related]  

  • 49. Prochlorperazine and chlorpromazine: a comparative clinical trial.
    SUNDBY P; LIEN JB
    Acta Psychiatr Scand Suppl; 1959; 34(136):82-8. PubMed ID: 13835720
    [No Abstract]   [Full Text] [Related]  

  • 50. Chlorpromazine, triflupromazine, and prochlorperazine in chronic pysychosis.
    HANLON TE; OTA KY; LIVCHITZ C; KURLAND AA
    AMA Arch Gen Psychiatry; 1959 Aug; 1():223-7. PubMed ID: 14399520
    [No Abstract]   [Full Text] [Related]  

  • 51. [Action of chlorpromazine in the treatment of systematized delirious psychoses and schizophrenia].
    BARRES P; LABOUCARIE J; RASCOL A
    Encephale; 1956; 45(4):691-7. PubMed ID: 13384286
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of chlorpromazine on the behavior of chronically overactive psychotic patients.
    ELKES J; ELKES C
    Br Med J; 1954 Sep; 2(4887):560-5. PubMed ID: 13182280
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effect of microdoses of Aminazin on healthy and psychic subjects].
    SKRIABIN GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1962; 62():219-22. PubMed ID: 13913713
    [No Abstract]   [Full Text] [Related]  

  • 54. A double-blind controlled comparison of the effects of chlorpromazine, barbiturate and a placebo in 142 chronic psychotic in-patients.
    LITTLE JC
    J Ment Sci; 1958 Apr; 104(435):334-49. PubMed ID: 13564138
    [No Abstract]   [Full Text] [Related]  

  • 55. [A chronic psychiatric department after a year's collective use of neuroplegics].
    STEPANEK J
    Cesk Psychiatr; 1962 Apr; 58():125-6. PubMed ID: 13916853
    [No Abstract]   [Full Text] [Related]  

  • 56. Chlorpromazine alone and with reserpine; use in the treatment of mental diseases.
    HOLLISTER LE; JONES KP; BROWNFIELD B; JOHNSON F
    Calif Med; 1955 Sep; 83(3):218-21. PubMed ID: 13250424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experiences with chlorpromazine in the psychiatric and neurological clinic.
    FLUGEL F
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1954; 279():767-72. PubMed ID: 13234555
    [No Abstract]   [Full Text] [Related]  

  • 58. Investigation of a new compound, B.W.203, and of chlorpromazine in the treatment of psychosis.
    FLEMING BG; CURRIE JD
    J Ment Sci; 1958 Jul; 104(436):749-57. PubMed ID: 13588332
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of tranquilizers upon pathological activity in psychotic patients. I. Chlorpromazine.
    CUTLER RP; MONROE JJ; ANDERSON TE
    AMA Arch Neurol Psychiatry; 1957 Jun; 77(6):616-22. PubMed ID: 13423935
    [No Abstract]   [Full Text] [Related]  

  • 60. Similar antiphlogistic reactions after prefrontal lobotomy and treatment with chlorpromazine.
    KRAMER HC
    J Nerv Ment Dis; 1956 Jan; 123(1):72-8. PubMed ID: 13346365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.